ME00563A - Process for preparing optically pure active compounds - Google Patents
Process for preparing optically pure active compoundsInfo
- Publication number
- ME00563A ME00563A MEP-848/08A MEP84808A ME00563A ME 00563 A ME00563 A ME 00563A ME P84808 A MEP84808 A ME P84808A ME 00563 A ME00563 A ME 00563A
- Authority
- ME
- Montenegro
- Prior art keywords
- optically pure
- active compounds
- pure active
- preparing optically
- chiral
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 abstract 1
- 229910052735 hafnium Inorganic materials 0.000 abstract 1
- VBJZVLUMGGDVMO-UHFFFAOYSA-N hafnium atom Chemical compound [Hf] VBJZVLUMGGDVMO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052726 zirconium Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Pyrrole Compounds (AREA)
- Catalysts (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02027273 | 2002-12-06 | ||
| DE10340255 | 2003-08-29 | ||
| PCT/EP2003/013605 WO2004052882A1 (en) | 2002-12-06 | 2003-12-03 | Process for preparing optically pure active compounds |
| YU20050423A RS52667B (en) | 2002-12-06 | 2003-12-03 | PROCEDURE FOR PREPARING OPTICALLY CLEAN UNITS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ME00563A true ME00563A (en) | 2011-12-20 |
Family
ID=32509784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-848/08A ME00563A (en) | 2002-12-06 | 2003-12-03 | Process for preparing optically pure active compounds |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7452998B2 (ru) |
| EP (1) | EP1578742B1 (ru) |
| JP (1) | JP4612542B2 (ru) |
| KR (1) | KR101062806B1 (ru) |
| CN (1) | CN100482658C (ru) |
| AR (1) | AR042277A1 (ru) |
| AU (1) | AU2003289948B2 (ru) |
| BR (2) | BR0317005A (ru) |
| CA (1) | CA2507807C (ru) |
| CY (1) | CY1114058T1 (ru) |
| DK (1) | DK1578742T3 (ru) |
| EA (1) | EA011771B1 (ru) |
| ES (1) | ES2397380T3 (ru) |
| HK (1) | HK1078864A1 (ru) |
| HR (1) | HRP20050604B1 (ru) |
| IL (1) | IL168456A (ru) |
| IS (1) | IS2885B (ru) |
| ME (1) | ME00563A (ru) |
| MX (1) | MXPA05005762A (ru) |
| NO (1) | NO330978B1 (ru) |
| NZ (1) | NZ540815A (ru) |
| PL (1) | PL375818A1 (ru) |
| PT (1) | PT1578742E (ru) |
| RS (1) | RS52667B (ru) |
| SI (1) | SI1578742T1 (ru) |
| TW (1) | TWI313268B (ru) |
| WO (1) | WO2004052882A1 (ru) |
| ZA (1) | ZA200503543B (ru) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE556713T1 (de) | 1999-01-13 | 2012-05-15 | Bayer Healthcare Llc | Omega-carboxyarylsubstituierte-diphenyl- harnstoffe als p38-kinasehemmer |
| JP2006514985A (ja) | 2002-12-06 | 2006-05-18 | アルタナ ファルマ アクチエンゲゼルシャフト | （ｓ）−パントプラゾールの製造方法 |
| FR2848555B1 (fr) * | 2002-12-16 | 2006-07-28 | Negma Gild | Enantiomere(-)du tenatoprazole et son application en therapeutique |
| EP1572680A2 (en) * | 2002-12-19 | 2005-09-14 | Eva Pharmaceutical Industries Ltd. | Solid states of pantoprazole sodium, known pantoprazole sodium hydrates, processes for their preparation. |
| EP1615913A2 (en) * | 2003-06-10 | 2006-01-18 | Teva Pharmaceutical Industries Limited | Process for preparing 2-(pyridinyl)methyl sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole |
| CN1960987A (zh) * | 2004-06-02 | 2007-05-09 | 奥坦纳医药公司 | 制备吡啶－2－基甲基亚磺酰基－1h－苯并咪唑类化合物的方法 |
| FR2871800B1 (fr) * | 2004-06-17 | 2006-08-25 | Sidem Pharma Sa Sa | Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique |
| NZ551970A (en) * | 2004-06-24 | 2010-01-29 | Astrazeneca Ab | New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt |
| EP1801110A1 (en) | 2005-12-22 | 2007-06-27 | KRKA, tovarna zdravil, d.d., Novo mesto | Esomeprazole arginine salt |
| US7579476B2 (en) * | 2006-02-24 | 2009-08-25 | Praktikatalyst Pharma, Llc | Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals |
| US8173818B2 (en) | 2006-08-08 | 2012-05-08 | Jubilant Organosys Limited | Process for producing sulphoxide compounds |
| WO2008047681A1 (fr) | 2006-10-13 | 2008-04-24 | Eisai R & D Management Co., Ltd. | Benzimidazole présentant une activité inhibitrice de la sécrétion d'acide gastrique |
| US20080103169A1 (en) | 2006-10-27 | 2008-05-01 | The Curators Of The University Of Missouri | Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same |
| EP2265605A4 (en) * | 2008-03-18 | 2011-08-03 | Reddys Lab Ltd Dr | METHOD OF MANUFACTURING DEXLANSOPRAZOLE AND POLYMORPHIDE THEREOF |
| EP2143722A1 (en) | 2008-07-09 | 2010-01-13 | Lek Pharmaceuticals D.D. | Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium |
| EP2264024A1 (en) | 2008-10-14 | 2010-12-22 | LEK Pharmaceuticals d.d. | Process for the preparation of enantiomerically enriched proton pump inhibitors |
| US8071781B2 (en) | 2008-11-11 | 2011-12-06 | Syn-Tech Chem. & Pharm. Co., Ltd. | Process for preparing rabeprazole sodium |
| ES2523921T3 (es) | 2010-02-12 | 2014-12-02 | Esteve Química, S.A. | Procedimiento de preparación de la sal sódica de esomeprazol |
| CN103113351B (zh) * | 2013-03-08 | 2015-01-21 | 苏州特瑞药业有限公司 | 一种光学纯手性亚砜类化合物的制备方法 |
| CN103936714A (zh) * | 2014-04-15 | 2014-07-23 | 北京华禧联合科技发展有限公司 | 一种埃索美拉唑镁的制备方法 |
| WO2016104668A1 (ja) * | 2014-12-26 | 2016-06-30 | 国立大学法人 東京大学 | 光学活性のプロトンポンプ阻害化合物の製造方法 |
| CN105440018A (zh) * | 2015-11-27 | 2016-03-30 | 福州闽海药业有限公司 | 一种锆催化的右旋兰索拉唑的不对称氧化合成方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| IL75400A (en) | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
| JPS6150978A (ja) | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
| FI90544C (fi) | 1986-11-13 | 1994-02-25 | Eisai Co Ltd | Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi |
| SE465514B (sv) | 1990-02-19 | 1991-09-23 | Curt Pettersson | Foerfarande och anvaendning av ett separationsmedium vid separation av enantiomerer |
| DE4035455A1 (de) | 1990-11-08 | 1992-05-14 | Byk Gulden Lomberg Chem Fab | Enantiomerentrennung |
| JPH08509736A (ja) | 1993-04-27 | 1996-10-15 | セプラコー，インコーポレイテッド | 光学的に純粋な（−）パントプラゾールを用いる胃の疾患治療の方法と組成 |
| EP0700292A4 (en) | 1993-04-27 | 1996-09-11 | Sepracor Inc | METHOD AND COMPOSITIONS FOR THE TREATMENT OF STOMACH DISEASES USING OPTICALLY PURE (+) - PANTOPRAZOLE |
| SE9301830D0 (sv) | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
| SE504459C2 (sv) * | 1994-07-15 | 1997-02-17 | Astra Ab | Förfarande för framställning av substituerade sulfoxider |
| GB9423968D0 (en) | 1994-11-28 | 1995-01-11 | Astra Ab | Resolution |
| GB9423970D0 (en) | 1994-11-28 | 1995-01-11 | Astra Ab | Oxidation |
| HRP960232A2 (en) | 1995-07-03 | 1998-02-28 | Astra Ab | A process for the optical purification of compounds |
| JP2006514985A (ja) * | 2002-12-06 | 2006-05-18 | アルタナ ファルマ アクチエンゲゼルシャフト | （ｓ）−パントプラゾールの製造方法 |
-
2003
- 2003-12-03 EA EA200500898A patent/EA011771B1/ru not_active IP Right Cessation
- 2003-12-03 RS YU20050423A patent/RS52667B/en unknown
- 2003-12-03 BR BR0317005-5A patent/BR0317005A/pt unknown
- 2003-12-03 MX MXPA05005762A patent/MXPA05005762A/es active IP Right Grant
- 2003-12-03 CA CA2507807A patent/CA2507807C/en not_active Expired - Fee Related
- 2003-12-03 PT PT37822889T patent/PT1578742E/pt unknown
- 2003-12-03 ES ES03782288T patent/ES2397380T3/es not_active Expired - Lifetime
- 2003-12-03 NZ NZ540815A patent/NZ540815A/en not_active IP Right Cessation
- 2003-12-03 EP EP03782288A patent/EP1578742B1/en not_active Expired - Lifetime
- 2003-12-03 PL PL03375818A patent/PL375818A1/xx not_active Application Discontinuation
- 2003-12-03 JP JP2005502310A patent/JP4612542B2/ja not_active Expired - Fee Related
- 2003-12-03 SI SI200332234T patent/SI1578742T1/sl unknown
- 2003-12-03 AR ARP030104447A patent/AR042277A1/es unknown
- 2003-12-03 ME MEP-848/08A patent/ME00563A/xx unknown
- 2003-12-03 DK DK03782288.9T patent/DK1578742T3/da active
- 2003-12-03 WO PCT/EP2003/013605 patent/WO2004052882A1/en active Application Filing
- 2003-12-03 AU AU2003289948A patent/AU2003289948B2/en not_active Ceased
- 2003-12-03 US US10/536,766 patent/US7452998B2/en not_active Expired - Fee Related
- 2003-12-03 CN CNB2003801044100A patent/CN100482658C/zh not_active Expired - Fee Related
- 2003-12-03 BR BRPI0310118A patent/BRPI0310118B1/pt not_active IP Right Cessation
- 2003-12-03 KR KR1020057009778A patent/KR101062806B1/ko not_active IP Right Cessation
- 2003-12-05 TW TW092134409A patent/TWI313268B/zh not_active IP Right Cessation
-
2005
- 2005-05-04 ZA ZA200503543A patent/ZA200503543B/en unknown
- 2005-05-05 IL IL168456A patent/IL168456A/en not_active IP Right Cessation
- 2005-06-23 IS IS7909A patent/IS2885B/is unknown
- 2005-06-24 NO NO20053099A patent/NO330978B1/no not_active IP Right Cessation
- 2005-06-29 HR HRP20050604AA patent/HRP20050604B1/hr not_active IP Right Cessation
- 2005-11-28 HK HK05110824.6A patent/HK1078864A1/xx not_active IP Right Cessation
-
2013
- 2013-01-07 CY CY20131100012T patent/CY1114058T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ME00563A (en) | Process for preparing optically pure active compounds | |
| ECSP034865A (es) | Resolución óptica de (1-benzilo-4-metilopiperidina-3-il)-metilamina y su uso para la preparación de derivados de pirrolo 2,3-pirimidina como inhibidores de proteina quinasas | |
| FR2889526B1 (fr) | 7-aza-indazoles substitues, compositions les contenant, procede de fabrication et utilisation | |
| MXPA04004464A (es) | Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades. | |
| AP1635A (en) | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease. | |
| CO6190512A2 (es) | Compuestos antagonistas del receptor de glucagon composiciones que contienen dichos compuestos y procedimientos de uso | |
| DE60329237D1 (de) | Kristalline form von linezolid | |
| DK1633697T3 (da) | Fremgangsmåde til fremstilling af substituerede 3-aryl-butyl-aminforbindelser | |
| PE20070619A1 (es) | TIENO(2,3-b)PIRIDIN-5-CARBONITRILOS COMO INHIBIDORES DE PROTEINAS QUINASA | |
| CO5690637A2 (es) | Tiazol-(bi) cicloalquil-carboxanilidas | |
| TNSN04250A1 (en) | Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof. | |
| BR0311984A (pt) | Difenilazetidinonas substituìdas cationicamente, processo para a sua preparação, medicamentos contendo estes compostos e sua aplicação | |
| ATE302756T1 (de) | Kristalline formen von fluvastatin sodium | |
| ATE388695T1 (de) | Pharmazeutische zusammensetzung enthaltend ein benzimidazol-derivat gemischt mit mikrokristalliner cellulose | |
| ATE345340T1 (de) | N-substituierte-1h-indol-5-propansäure verbindungen als ppar-agonisten zur behandlung von diabetis | |
| TW200510376A (en) | Process for preparing (s)-pantoprazole | |
| HK1099759A1 (en) | A process for the resolution of nefopam | |
| DE69300453D1 (de) | Isoindolinon-derivat, seine herstellung und dieses enthaltende pharmazeutische zusammen setzungen. | |
| ATE481408T1 (de) | Reinigung von beta-lactam-verbindungen | |
| DE502004009136D1 (de) | NEUE HETEROARYLSUBSTITUIERTE ACETONDERIVATE ALS HEMMSTOFFE DER PHOSPHOLIPASE A sb 2 /sb | |
| NO20062041L (no) | Fremgangsmater for fremstille forbindelser som kan anvendes som proteaseinhibitoere | |
| DE602004014739D1 (de) | Chemoenzymatisches verfahren zur stereoselektiven herstellung von optisch-angereicherten phenylglycidate | |
| ATE282726T1 (de) | Herstellung von verbindungen auf basis von cu-in- se phasengleichgewichten | |
| EA200600699A1 (ru) | Способы получения соединений бензоксазолсульфонамида и их промежуточные соединения | |
| ATE299532T1 (de) | Chemo-enzymatische synthese von optisch- angereicherten rosenoxiden |